Travere Therapeutics (TVTX) Short-term Investments (2013 - 2018)
Travere Therapeutics (TVTX) recorded Short-term Investments of $166.38 million in Q2 2018, down 19.5% from $206.72 million a year earlier and down 18.0% from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Short-term Investments (2013 - 2018) Analysis & Trends
At the end of FY2017, Travere Therapeutics reported Short-term Investments of $201.24 million, down 6.3% from FY2016.
- Annual Short-term Investments has a four-year compound annual growth rate of 523.7% (FY2013 to FY2017).
- Across earlier years, Short-term Investments came in at $214.87 million in FY2016 (+12.0%), $191.8 million in FY2015, $9.56 million in FY2014 and $132,994 in FY2013.
- The Q2 2018 figure is the lowest quarterly Short-term Investments since Q3 2015.
- On a year-over-year basis, Short-term Investments has declined for four consecutive quarters, with growth averaging 17.2% over the last eight quarters.
- Peak year-over-year performance for Short-term Investments in the last five years was growth of 693.6% in Q3 2015, against a decline of 19.5% in Q2 2018 at the low end.
- Per Business Quant, the preceding three quarters came in at $202.94 million (Q1 2018), $201.24 million (Q4 2017) and $204.88 million (Q3 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Travere Therapeutics | 5.36 Bn | 4.96 Bn | 167.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 166.38 Mn |
| Mar 31, 2018 | 202.94 Mn |
| Dec 31, 2017 | 201.24 Mn |
| Sep 30, 2017 | 204.88 Mn |
| Jun 30, 2017 | 206.72 Mn |
| Mar 31, 2017 | 206.29 Mn |
| Dec 31, 2016 | 214.87 Mn |
| Sep 30, 2016 | 250.41 Mn |
| Jun 30, 2016 | 200.36 Mn |
| Mar 31, 2016 | 199.08 Mn |
| Dec 31, 2015 | 191.80 Mn |
| Sep 30, 2015 | 94.68 Mn |
| Jun 30, 2015 | 5.86 Mn |
| Mar 31, 2015 | 6.16 Mn |
| Dec 31, 2014 | 9.56 Mn |
| Sep 30, 2014 | 11.93 Mn |
| Dec 31, 2013 | 132,994.00 |
API Access
Travere Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();